US 12,419,909 B2
Hypochlorous acid intravenous solution, preparation, and method of use thereof
Danyel Armando Arenas, Santander (CO)
Assigned to BIIOSMART TECHNOLOGIES LLC, Miami, FL (US)
Appl. No. 17/431,234
Filed by BIIOSMART TECHNOLOGIES LLC, Miami, FL (US)
PCT Filed Feb. 20, 2020, PCT No. PCT/US2020/018966
§ 371(c)(1), (2) Date Aug. 16, 2021,
PCT Pub. No. WO2020/172363, PCT Pub. Date Aug. 27, 2020.
Claims priority of provisional application 62/807,787, filed on Feb. 20, 2019.
Prior Publication US 2022/0133779 A1, May 5, 2022
Int. Cl. A61K 33/20 (2006.01)
CPC A61K 33/20 (2013.01) 10 Claims
 
1. A method of treating an infection, comprising providing an effective amount of an intravenous solution composition to a subject in need thereof, the intravenous solution composition comprises
about 0.010% to about 0.040% hypochlorous acid (HOCl);
about 0.05 to about 0.35% in NaCl;
about 0.005% to about 0.020% in OCl; and
water,
wherein all the % are by percentage over the total volume of the intravenous solution, and
wherein the composition has a pH of about 5.2 to about 6.2; and
wherein the intravenous solution composition is provided to the subject in an amount of about 1 to about 20 ml of the intravenous solution composition once per day for a total of about 4 to about 6 doses; or once every 48 hours for a total of about 4 to about 6 doses.